Product Program year 2025 Source: CMS Open Payments

SpiderFX

Device Embolic Protection Devices

PDI 00821684068366

Open in the dashboard

General payments

$53,948

1,146 payments

Research payments

$0

0 payments

Through program year 2025, $53,948 in general payments and $0 in research payments were reported against SpiderFX (Embolic Protection Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $15,474 390
2024 General $5,346 227
2023 General $17,119 216
2022 General $9,138 133
2021 General $6,871 180

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $53,948 1,146 payments
Top recipients General payments · program year 2025
  1. Rodney Raabe Vascular & Interventional Radiology · Spokane, WA $2,700 17% · 1 payment
  2. John Winscott Interventional Cardiology · Jackson, MS $538 3% · 12 payments
  3. Brian Bronzo Vascular & Interventional Radiology · San Francisco, CA $325 2% · 3 payments
  4. Venu Vadlamudi Diagnostic Radiology · South Bend, IN $246 2% · 2 payments
  5. Michael Ginsburg Vascular & Interventional Radiology · South Bend, IN $246 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular & Interventional Radiology Radiology $4,815 32% · 35 practitioners
  2. Interventional Cardiology Internal Medicine $3,111 20% · 58 practitioners
  3. Vascular Surgery Surgery $2,938 19% · 81 practitioners
  4. Cardiovascular Disease Internal Medicine $1,341 9% · 26 practitioners
  5. Diagnostic Radiology Radiology $695 5% · 16 practitioners

The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Washington $2,731 18% · 2 recipients
  2. Mississippi $2,236 14% · 16 recipients
  3. Indiana $1,651 11% · 30 recipients
  4. Texas $1,079 7% · 26 recipients
  5. New York $994 6% · 22 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,146 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record